You can buy or sell MDNA and other stocks, options, and ETFs commission-free!
Medicenna Therapeutics Corp. Common Shares, also called Medicenna Therapeutics, is a clinical stage immuno-oncology company which engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada. The listed name for MDNA is Medicenna Therapeutics Corp. Common Shares.
52 Week High
52 Week Low